The earliest that an approved version of generic Evista could be available is in July 2012, when the first patent for the drug expires. So-called generic versions may be available on the Internet, but there is no way of knowing how safe these drugs are or if you are even getting genuine Evista. Once the [...]

No studies have been done on Evista and breastfeeding because it is often considered unethical to do so; infants cannot consent to the tests and generally do not directly benefit from them. The manufacturer recommends that women not take the drug while breastfeeding. However, each woman’s situation is unique, so you and your healthcare provider [...]

In animal studies on Evista and pregnancy, the drug caused a range of problems, from miscarriages and birth defects to delayed labor and delivery. As a result, the FDA assigned a pregnancy Category X rating to Evista - this means it should never be taken by a pregnant woman. If you are taking Evista and [...]

Arming your postmenopausal patients with knowledge about the health risks they may face - and the steps they can take to help prevent them - will help empower them to take charge of their health.
Osteoporosis Quick Facts
The following facts compiled by the National Osteoporosis Foundation1 will help your patients [...]

EVISTA has been prescribed by doctors for over 10 years to help keep bones strong and help prevent spinal fractures due to postmenopausal osteoporosis. EVISTA stops the thinning of the bones, increases bone mineral density, and helps restore the bone turn-over rate (the process of breaking down [...]

Evista is prescribed to treat and prevent osteoporosis, the brittle-bone disease that strikes some women after menopause. A variety of factors promote osteoporosis. The more factors that apply to you, the greater your chances of developing the disease.